Breast Tumor Localization Implant Removes Time Constraints
By HospiMedica International staff writers Posted on 29 Nov 2017 |

Image: The Savi Scout surgical guidance system (Photo courtesy of Cianna Medical).
A novel non-radioactive breast tumor localization system used can be implanted with no restrictions on the length of time the reflector can remain in the breast.
The Cianna Medical (Aliso Viejo, CA, USA) Savi Scout breast tumor localization system uses electromagnetic (EM) wave technology to provide real-time audible and visual indicators for target tissue acquisition during breast conservation procedures, with a 360˚ detection capability and a pinpoint accuracy of one millimeter. The system is based on a passive reflector placed in the target tissue prior to surgery by an interventional radiologist. During the procedure, the surgeon uses a special handpiece that emits EM radar waves to locate the reflector and plan the incision.
The reflector is completely passive until activated, allowing patients to continue with all activities; and because it does not interfere with magnetic resonance imaging (MRI) scans, it provides physicians with maximum flexibility for its localization at any time during the continuum of care. During the lumpectomy or surgical biopsy, the surgeon scans the breast using the Scout guide, which emits 50 million pulses per second, in order to lock on to the reflector’s position. The reflector and target tissue can then be safely removed.
“I applaud the vision of all our physicians and health systems who are leading the way in offering a new standard of care in breast tumor localization,” said Jill Anderson, President and CEO of Cianna Medical. “Scout has become the most precise and broadly applicable non-wire localizing system in the industry, and more than 170 leading medical centers across the United States have adopted Scout radar breast localization and surgical guidance system as an alternative to placing wires on the day of surgery.”
The standard preoperative technique for localizing non-palpable breast lesions, developed more than 20 years ago, is wire localization, which involves a radiopaque wire inserted into the breast by a radiologist prior to surgery using mammography or ultrasound guidance. The surgeon can subsequently be guided directly to the target tissue.
Related Links:
Cianna Medical
The Cianna Medical (Aliso Viejo, CA, USA) Savi Scout breast tumor localization system uses electromagnetic (EM) wave technology to provide real-time audible and visual indicators for target tissue acquisition during breast conservation procedures, with a 360˚ detection capability and a pinpoint accuracy of one millimeter. The system is based on a passive reflector placed in the target tissue prior to surgery by an interventional radiologist. During the procedure, the surgeon uses a special handpiece that emits EM radar waves to locate the reflector and plan the incision.
The reflector is completely passive until activated, allowing patients to continue with all activities; and because it does not interfere with magnetic resonance imaging (MRI) scans, it provides physicians with maximum flexibility for its localization at any time during the continuum of care. During the lumpectomy or surgical biopsy, the surgeon scans the breast using the Scout guide, which emits 50 million pulses per second, in order to lock on to the reflector’s position. The reflector and target tissue can then be safely removed.
“I applaud the vision of all our physicians and health systems who are leading the way in offering a new standard of care in breast tumor localization,” said Jill Anderson, President and CEO of Cianna Medical. “Scout has become the most precise and broadly applicable non-wire localizing system in the industry, and more than 170 leading medical centers across the United States have adopted Scout radar breast localization and surgical guidance system as an alternative to placing wires on the day of surgery.”
The standard preoperative technique for localizing non-palpable breast lesions, developed more than 20 years ago, is wire localization, which involves a radiopaque wire inserted into the breast by a radiologist prior to surgery using mammography or ultrasound guidance. The surgeon can subsequently be guided directly to the target tissue.
Related Links:
Cianna Medical
Latest Surgical Techniques News
- Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery
- LED-Based Imaging System Could Transform Cancer Detection in Endoscopy
- New Surgical Microscope Offers Precise 3D Imaging Using 48 Tiny Cameras
- First-Of-Its-Kind Drug Illuminates Nerve Tissue for Faster and Safer Surgery
- Neuroform Atlas Stent-Assisted Coiling Found Effective Even in Smaller Arteries
- New Surgical Technique Safely Removes Giant Nerve Tumors
- Breakthrough Polymer Significantly Improves Safety of Implantable Medical Devices
- First-Ever Technology Makes Blood Translucent During Surgery
- Tibia Nailing System with Novel Side-Specific Nails to Revolutionize Fracture Surgery
- New Imaging Probe to Transform Brain Cancer Surgery
- New Technology More Than Doubles Success Rate for Blood Clot Removal
- Surgical Ablation During CABG Improves Survival in Patients with Preexisting Atrial Fibrillation
- New Battery Technology Delivers Additional Power to Implantable Medical Devices
- New Model Reveals Optimal Positioning of Orthopedic Screws in Fractures
- Non-Invasive Tool for Removing Lung Cancer Tumors Reduces Surgical Trauma
- Advanced Imaging Endoscopes to Revolutionize Detection and Treatment of Gastrointestinal Disorders
Channels
Critical Care
view channel
Skin-Like Sensor Monitors Vital Signs and Tracks Healing After Surgery
Medical conditions such as bladder control issues and the need for monitoring vital signs after surgery require precise, long-term tracking to improve patient outcomes. These conditions can be challenging... Read more
Wireless Implant Delivers Chemotherapy Deep into Tumors Without Side Effects
Solid tumors, such as those found in cancer patients, present a significant challenge in treatment due to their dense cellular structure and high interstitial pressure. Traditional drug therapies often... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more